Silk Road Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Silk Road Medical generated cash of -$32,014,000, which is more than the previous year. Cash used in financing activities reached the amount of $3,887,000 last year. Net change in cash is therefore -$35,148,000.
Cash Flow
| 2017 | -25.25M | -443K | 47.15M |
|---|---|---|---|
| 2018 | -21.69M | -2.27M | 15.42M |
| 2019 | -29.61M | -69.95M | 113.75M |
| 2020 | -42.06M | -9.39M | 81.74M |
| 2021 | -38.93M | 72.64M | 6.97M |
| 2022 | -32.58M | -162.06M | 139.69M |
| 2023 | -32.01M | -7.17M | 3.88M |
SILK Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 55.35M | 110.46M | 69.77M | 39.49M | 25.3M | 33.84M | 12.38M |
Operating activities | |||||||
Net income | -55.74M | -55.01M | -49.81M | -47.36M | -52.41M | -37.63M | -19.35M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 3.79M | 3.16M | 1.91M | 1.39M | 1.29M | 517K | 129K |
Stock-based compensation expense | 38.89M | 25.02M | 14.61M | 7.22M | 2.97M | 0 | 535K |
| Deferred income tax benefit | 38.89M | 25.02M | 14.61M | 7.22M | 2.97M | 0 | 535K |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | -5.61M | -6.17M | -2.76M | -437K | -2.24M | -1.00M | -4.79M |
Inventories | -10.78M | -1.44M | -5.56M | -2.16M | -4.69M | -2.56M | -2.40M |
Accounts payable | 3.06M | 967K | -1.15M | 592K | 615K | -309K | 678K |
Cash generated by operating activities | -32.01M | -32.58M | -38.93M | -42.06M | -29.61M | -21.69M | -25.25M |
Investing activities | |||||||
Purchases Of Investments | -174.96M | -168.16M | -2K | -79.90M | -69.42M | 0 | -309.64K |
Investments In Property Plant And Equipment | -1.50M | -5.00M | -4.75M | -842K | -535K | -2.27M | -443K |
Acquisitions Net | 5.66M | 157.06M | 2K | 8.55M | 0 | 0 | 576 |
Cash generated by investing activities | -7.17M | -162.06M | 72.64M | -9.39M | -69.95M | -2.27M | -443K |
Financing activities | |||||||
Common Stock Issued | 3.88M | 114.78M | 6.94M | 75.73M | 111.94M | 656K | 338K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 24.91M | 0 | -40M | 0 | 0 | 5M |
Cash used in financing activities | 3.88M | 139.69M | 6.97M | 81.74M | 113.75M | 15.42M | 47.15M |
Net Change In Cash | -35.14M | -54.95M | 40.68M | 30.28M | 14.19M | -8.54M | 21.46M |
Cash at end of period | 20.21M | 55.51M | 110.46M | 69.77M | 39.49M | 25.3M | 33.84M |
| Data source | Data source | Data source | Data source |